Curable formulations, cured compositions, and articles derived thereform
AssigneeGeneral Electric Company
InventorsBret Ja Chisholm, James Edward Pickett
Life of this patent
Estimating the term…
Abstract
Curable formulations comprising: (a) at least one multifunctional acrylate having a functionality of at least two, (b) at least one mono-acrylate monomer, (c) at least one heteroatom-containing diacrylate, wherein the heteroatom is sulfur or selenium; and (d) a curing agent, have been discovered. The curable formulations show promise as precursors to high refractive index materials suitable for use in light management devices and other optical devices. In addition the novel curable formulations are useful for producing coatings, which may be useful in forming display films, in particular brightness enhancing display films.
Claims15
A curable formulation comprising:
- (a) at least one multifunctional acrylate having a functionality of at least two;
- (b) at least one mono-acrylate monomer having structure XI
- wherein R5 is a hydrogen atom, a halogen atom, a C1-C10 aliphatic radical, a C3-C10 cycloaliphatic radical, or a C3-C10 aromatic radical;
- R6 is independently at each occurrence a hydrogen atom, halogen atom, a C1-C10 aliphatic radical, a C3-C10 cycloaliphatic radical, or a C3-C10 aromatic radical;
- and “e” is an integer from 1-4;
- (c) at least one heteroatom-containing diacrylate, wherein the heteroatom is selected from the group consisting of sulfur and selenium;
- and
- (d) at least one curing agent.
A curable formulation comprising:
- (a) at least one multifunctional acrylate having a functionality of at least two;
- (b) at least one mono-acrylate monomer selected from the group consisting of 1,3-bis(2-mercaptobenzothiazoyl)propan-2-yl (meth)acrylate;
- 1,3-bis(2-mercaptobenzothiazoyl)pronan-2-yl acrylate;
- (c) at least one heteroatom-containing diacrylate XIII
- wherein R8, R9, and R10 are independently at each occurrence a hydrogen atom, a halogen atom, a C1-C10 aliphatic radical, a C3-C10 cycloaliphatic radical, or a C3-C10 aromatic radical;
- L1 and L2 are independently at each occurrence a divalent C1-C10 aliphatic radical, a divalent C3-C10 cycloaliphatic radical, or a divalent C3-C10 aromatic radical;
- Q1, Q2, and Q3 are independently at each occurrence a bond, an oxygen atom, a carbonyl group, a thiocarbonyl group, a carbonyloxy group, an oxycarbonyl group, a sulfur atom, a selenium atom, a disulfide group, a diselenide group, a selenosulfide group, a sulfoxide group, a sulfone group, a selenoxide group or a selenone group, wherein at least one of Q1, Q2, and Q3 comprises a sulfur atom or a selenium atom;
- and Ar1 and Ar2 are independently C3-C10 divalent aromatic radicals;
- and
- (d) at least one curing agent.
Dependencies are inferred from the claim text.